IL6 and inflammatory bowel disease: IL-6 inhibition emerged as an appealing therapeutic avenue in view of its clear association with the pathogenesis of many diseases, ranging from bacterial and viral infections [7] to arthritis [8], inflammatory bowel diseases (IBD) [9], and multiple sclerosis [5, 10, 11].